Cargando…
A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury
In preclinical stages of drug development, anticipating potential adverse drug effects such as toxicity is an important issue for both saving resources and preventing public health risks. Current in vitro cytotoxicity tests are restricted by their predictive potential and their ability to provide me...
Autores principales: | García- Cañaveras, Juan Carlos, Castell, José V., Donato, M. Teresa, Lahoz, Agustín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893700/ https://www.ncbi.nlm.nih.gov/pubmed/27265840 http://dx.doi.org/10.1038/srep27239 |
Ejemplares similares
-
Tumor Microenvironment-Derived Metabolites: A Guide to Find New Metabolic Therapeutic Targets and Biomarkers
por: García-Cañaveras, Juan C., et al.
Publicado: (2021) -
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021) -
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022) -
Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis
por: Suay, Guillermo, et al.
Publicado: (2023) -
Cell-Based Metabolomics Approach for Anticipating and Investigating Cytotoxicity of Gold Nanorods
por: Ji, Jian, et al.
Publicado: (2022)